Distal enhancers: New insights into heart development and disease

Trends in Cell Biology

Volumn 24, Issue 5, 2014, Pages 294-302

  Wamstad, Joseph A ^a   Wang, Xinchen ^a   Demuren, Olukunle O ^a   Boyer, Laurie A ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Cardiac; Enhancers; Gene regulation; GWAS; Heart

Indexed keywords

TRANSCRIPTION FACTOR;

ANIMAL; CELL DIFFERENTIATION; CELL LINEAGE; CHROMATIN ASSEMBLY AND DISASSEMBLY; ENHANCER REGION; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HEART; HEART DISEASE; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CHROMATIN ASSEMBLY AND DISASSEMBLY; ENHANCER ELEMENTS, GENETIC; EPIGENESIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; HEART; HEART DISEASES; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCRIPTION FACTORS;

EID: 84899494117     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2013.10.008     Document Type: Review

References (84)

1. Banerji J., et al. Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences. Cell 1981, 27:299-308.
2. Atchison M.L. Enhancers: mechanisms of action and cell specificity. Annu. Rev. Cell Biol. 1988, 4:127-153.
3. Maston G.A., et al. Transcriptional regulatory elements in the human genome. Annu. Rev. Genomics Hum. Genet. 2006, 7:29-59.
4. Bulger M., Groudine M. Functional and mechanistic diversity of distal transcription enhancers. Cell 2011, 144:327-339.
5. O'Kane C.J., Gehring W.J. Detection in situ of genomic regulatory elements in Drosophila. Proc. Natl. Acad. Sci. U.S.A. 1987, 84:9123-9127.
6. Barski A., et al. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129:823-837.
7. Bonn S., et al. Cell type-specific chromatin immunoprecipitation from multicellular complex samples using BiTS-ChIP. Nat. Protoc. 2012, 7:978-994.
8. Rada-Iglesias A., et al. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 2010, 470:279-283.
9. Ernst J., et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011, 473:43-49.
10. Creyghton M.P., et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:21931-21936.
11. Visel A., et al. Enhancer identification through comparative genomics. Semin. Cell Dev. Biol. 2007, 18:140-152.
12. Visel A., et al. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 2009, 457:854-858.
13. Kharchenko P.V., et al. Comprehensive analysis of the chromatin landscape in Drosophila melanogaster. Nature 2010, 471:480-485.
14. Birney E., et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007, 447:799-816.
15. Dunham I., et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74.
16. Thurman R.E., et al. The accessible chromatin landscape of the human genome. Nature 2012, 489:75-82.
17. Bruneau B.G. The developmental genetics of congenital heart disease. Nature 2008, 451:943-948.
18. Olson E.N. Gene regulatory networks in the evolution and development of the heart. Science 2006, 313:1922-1927.
19. Bruneau B.G. Signaling and transcriptional networks in heart development and regeneration. Cold Spring Harb. Perspect. Biol. 2013, 5:a008292.
20. Srivastava D. Making or breaking the heart: from lineage determination to morphogenesis. Cell 2006, 126:1037-1048.
21. Spitz F., Furlong E.E.M. Transcription factors: from enhancer binding to developmental control. Nat. Rev. Genet. 2012, 13:613-626.
22. Chang C-P., Bruneau B.G. Epigenetics and cardiovascular development. Annu. Rev. Physiol. 2012, 74:41-68.
23. Zaidi S., et al. De novo mutations in histone-modifying genes in congenital heart disease. Nature 2013, 498:220-223.
24. Buecker C., Wysocka J. Enhancers as information integration hubs in development: lessons from genomics. Trends Genet. 2012, 28:276-284.
25. He A., et al. Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:2-7.
26. Junion G., et al. A transcription factor collective defines cardiac cell fate and reflects lineage history. Cell 2012, 148:473-486.
27. Narlikar L., et al. Genome-wide discovery of human heart enhancers. Genome Res. 2010, 20:381-392.
28. Blow M.J., et al. ChIP-Seq identification of weakly conserved heart enhancers. Nat. Genet. 2010, 42:818-822.
29. May D., et al. Large-scale discovery of enhancers from human heart tissue. Nat. Genet. 2012, 44:89-93.
30. Wamstad J.A., et al. Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage. Cell 2012, 151:206-220.
31. Zentner G.E., et al. Epigenetic signatures distinguish multiple classes of enhancers with distinct cellular functions. Genome Res. 2011, 21:1273-1283.
32. Taylor G., et al. H4K16 acetylation marks active genes and enhancers of embryonic stem cells, but does not alter chromatin compaction. Genome Res. 2013, 10.1101/gr.155028.113.
33. Bonn S., et al. Tissue-specific analysis of chromatin state identifies temporal signatures of enhancer activity during embryonic development. Nat. Genet. 2012, 44:148-156.
34. Whyte W.A., et al. Enhancer decommissioning by LSD1 during embryonic stem cell differentiation. Nature 2012, 482:221-225.
35. Mendenhall E.M., et al. Locus-specific editing of histone modifications at endogenous enhancers. Nat. Biotechnol. 2013, 10.1038/nbt.2701.
36. Stergachis A.B., et al. Developmental fate and cellular maturity encoded in human regulatory DNA landscapes. Cell 2013, 154:888-903.
37. Zhu J., et al. Genome-wide chromatin state transitions associated with developmental and environmental cues. Cell 2013, 152:642-654.
38. Smale S.T. Pioneer factors in embryonic stem cells and differentiation. Curr. Opin. Genet. Dev. 2010, 20:519-526.
39. Zaret K.S., Carroll J.S. Pioneer transcription factors: establishing competence for gene expression. Genes Dev. 2011, 25:2227-2241.
40. Xu J., et al. Transcriptional competence and the active marking of tissue-specific enhancers by defined transcription factors in embryonic and induced pluripotent stem cells. Genes Dev. 2009, 23:2824-2838.
41. Sérandour A.A., et al. Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers. Genome Res. 2011, 21:555-565.
42. Kim T-K., et al. Widespread transcription at neuronal activity-regulated enhancers. Nature 2010, 465:182-187.
43. Djebali S., et al. Landscape of transcription in human cells. Nature 2012, 489:101-108.
44. Lai F., et al. Activating RNAs associate with Mediator to enhance chromatin architecture and transcription. Nature 2013, 494:497-501.
45. Ørom U.A., et al. Long noncoding RNAs with enhancer-like function in human cells. Cell 2010, 143:46-58.
46. Melo C.A., et al. eRNAs are required for p53-dependent enhancer activity and gene transcription. Mol. Cell 2013, 49:524-535.
47. Lam M.T.Y., et al. Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription. Nature 2013, 498:511-515.
48. Li W., et al. Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature 2013, 498:516-520.
49. Kaikkonen M.U., et al. Remodeling of the enhancer landscape during macrophage activation is coupled to enhancer transcription. Mol. Cell 2013, 51:310-325.
50. Sanyal A., et al. The long-range interaction landscape of gene promoters. Nature 2012, 489:109-113.
51. Gibcus J.H., Dekker J. The hierarchy of the 3D genome. Mol. Cell 2013, 49:773-782.
52. De Wit E., de Laat W. A decade of 3C technologies: insights into nuclear organization. Genes Dev. 2012, 26:11-24.
53. Lieberman-Aiden E., et al. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 2009, 326:289-293.
54. Sexton T., et al. Three-dimensional folding and functional organization principles of the Drosophila genome. Cell 2012, 148:458-472.
55. Hou C., et al. Gene density, transcription, and insulators contribute to the partition of the Drosophila genome into physical domains. Mol. Cell 2012, 48:471-484.
56. Dixon J.R., et al. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature 2012, 485:376-380.
57. Nora E.P., et al. Spatial partitioning of the regulatory landscape of the X-inactivation centre. Nature 2012, 485:381-385.
58. Phillips-Cremins J.E., et al. Architectural protein subclasses shape 3D organization of genomes during lineage commitment. Cell 2013, 153:1281-1295.
59. Jin F., et al. A high-resolution map of the three-dimensional chromatin interactome in human cells. Nature 2013, 503:290-294.
60. Fullwood M.J., et al. An oestrogen-receptor-alpha-bound human chromatin interactome. Nature 2009, 462:58-64.
61. Li G., et al. Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation. Cell 2012, 148:84-98.
62. Handoko L., et al. CTCF-mediated functional chromatin interactome in pluripotent cells. Nat. Genet. 2011, 43:630-638.
63. Kagey M.H., et al. Mediator and cohesin connect gene expression and chromatin architecture. Nature 2010, 467:430-435.
64. Whyte W.A., et al. Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 2013, 153:307-319.
65. Hnisz D., et al. Super-enhancers in the control of cell Identity and disease. Cell 2013, 55:934-947.
66. Parker S.C.J., et al. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:17921-17926.
67. Tuan D., et al. The 'beta-like-globin' gene domain in human erythroid cells. Proc. Natl. Acad. Sci. U.S.A. 1985, 82:6384-6388.
68. Forrester W.C., et al. A developmentally stable chromatin structure in the human beta-globin gene cluster. Proc. Natl. Acad. Sci. U.S.A. 1986, 83:1359-1363.
69. Montavon T., et al. A regulatory archipelago controls Hox genes transcription in digits. Cell 2011, 147:1132-1145.
70. Lovén J., et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell 2013, 153:320-334.
71. Delmore J.E., et al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 2011, 146:904-917.
72. Lettice L.A. A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly. Hum. Mol. Genet. 2003, 12:1725-1735.
73. Smemo S., et al. Regulatory variation in a TBX5 enhancer leads to isolated congenital heart disease. Hum. Mol. Genet. 2012, 21:3255-3263.
74. Maurano M.T., et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 2012, 337:1190-1195.
75. Musunuru K., et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 2010, 466:714-719.
76. Ward L.D., Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012, 40:D930-D934.
77. Cong L., et al. Multiplex genome engineering using CRISPR/Cas systems. Science 2013, 339:819-823.
78. Mali P., et al. RNA-guided human genome engineering via Cas9. Science 2013, 339:823-826.
79. Patwardhan R.P., et al. Massively parallel functional dissection of mammalian enhancers in vivo. Nat. Biotechnol. 2012, 30:265-270.
80. Melnikov A., et al. Systematic dissection and optimization of inducible enhancers in human cells using a massively parallel reporter assay. Nat. Biotechnol. 2012, 30:271-277.
81. Kheradpour P., et al. Systematic dissection of regulatory motifs in 2000 predicted human enhancers using a massively parallel reporter assay. Genome Res. 2013, 23:800-811.
82. Sharon E., et al. Inferring gene regulatory logic from high-throughput measurements of thousands of systematically designed promoters. Nat. Biotechnol. 2012, 30:521-530.
83. Blanchette M. Genome-wide computational prediction of transcriptional regulatory modules reveals new insights into human gene expression. Genome Res. 2006, 16:656-668.
84. Visel A., et al. VISTA Enhancer Browser - a database of tissue-specific human enhancers. Nucleic Acids Res. 2007, 35:D88-D92.